First Tracks Biotherapeutics TRAX

First Tracks Biotherapeutics, Inc. · Nasdaq · Pharmaceutical Preparations

$45.72+0.75%close on Oct. 28, 2026 · volume 641K · Yahoo Finance

Price, last 47 sessions

$35.00$40.00$45.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $45.72 · low $30.59 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 2, 2026J. Anthony Ware
director
Sold39,265$44.78$1.76 million

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 20 →
  • SCHEDULE 13G/AOct. 27, 2026, 5:25 p.m. ETView on SEC.gov
  • S-1Oct. 26, 2026, 7:37 a.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 4:05 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Financial statements and exhibits

    AI summary, unreviewedFirst Tracks Biotherapeutics closes private placement of 6,106,870 shares with resale registration rights

  • 8-KOct. 15, 2026, 4:28 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits

  • 8-KOct. 13, 2026, 8:32 a.m. ETView on SEC.gov

    Regulation FD disclosure · Other events · Financial statements and exhibits

  • 4Sept. 17, 2026, 4:05 p.m. ETView on SEC.gov
  • 4Sept. 4, 2026, 4:25 p.m. ETView on SEC.gov
  • 4Aug. 18, 2026, 4:05 p.m. ETView on SEC.gov